This review systematically addresses the evidence confirming polycystic ovary syndrome (PCOS) as a cardiovascular health threat. Literature in this area is void of long-term prospective studies to adequately evaluate outcome, but there is important evidence using surrogate markers for future development of and presence of cardiovascular disease and diabetes in women with PCOS. In addition, this article reviews the evidence regarding evaluation and management of cardiovascular risk factors in the population of women with PCOS. We seek to review the literature to determine when or if recommendations for management of women with PCOS should deviate from guidelines for the population at large.
Abstract:The increasing use of methotrexate for multiple indications in reproductive age women will likely lead to more frequent incidence of fetal exposure. Methotrexate is sometimes used for medical termination of first trimester pregnancy in combination with misoprostol. Teratogenesis in women exposed to low-dose methotrexate used for treatment of rheumatic conditions has been reported, but it has also been suggested that there is no teratogenic risk associated with low-dose exposure. Because medical termination with methotrexate and misoprostol has high success rates, reports of anomalies in ongoing pregnancies are rare. A 19-year-old gravida 3, para 1 presented in the third trimester after failing an attempt at medical termination with methotrexate. Ultrasonography revealed an absent right kidney and concern for stenosis of the tricuspid valve. After delivery, the absence of the right kidney was confirmed as well as a ventricular septal defect. Low-dose methotrexate, even in a single dose, may be associated with fetal anomalies. Caution must be taken with the use of methotrexate for termination of pregnancy. Patient reliability, adequate follow-up and appropriate counseling for the risk of failure are essential.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.